Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone

BACKGROUND: Gemcitabine is a pyrimidine nucleoside analog that is a commonly used chemotherapeutic agent for unresectable or recurrent biliary tract cancer (BTC). Several molecules involved in gemcitabine metabolism, including human equilibrative nucleoside transporter (hENT1), deoxycytidine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Akihiro, Amano, Ryosuke, Yamada, Nobuya, Kimura, Kenjiro, Yashiro, Masakazu, Nakata, Bunzo, Hirakawa, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669607/
https://www.ncbi.nlm.nih.gov/pubmed/23710668
http://dx.doi.org/10.1186/1477-7819-11-117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669607/
https://www.ncbi.nlm.nih.gov/pubmed/23710668
http://dx.doi.org/10.1186/1477-7819-11-117

Ejemplares similares